Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: ewolf who wrote (2537)	4/3/1999 6:52:00 PM
From: Art Bechhoefer	Respond to of 4676

I wish ISIS would give people more information about results from testing its drugs in experimental settings. For example, there is a web site devoted entirely to coordinating new treatments for brain cancer. ISIS has a compound under test at a number of hospitals, which is reported on this web site, and there must be other tests going on for other drugs as well. Even though one can't draw any valid conclusions from a single, or even a handful of tests, just knowing what's going on, and how long the tests have been in progress might help investors.